| Micro-channel |
 |
|
|
|
|
|
| |
| The ministry of industry and information technology announced that in the first half of 2017, the most profitable part of the film is the beverage. |
| |
| Author：中國銘鉉 企劃部 Release Time：2017-8-28 10:17:39 Number Browse：782 |
| |
Medical network - on August 28, the ministry's latest pharmaceutical industry in the first half of 2017, according to the main economic indicators to complete comprehensive advocate business wu income, overall profit, Chinese medicine yinpian in the pharmaceutical industry, there is no doubt become the biggest winner in the first half of 2017.
In the first half of 2017, the added value of the pharmaceutical industry is over 10%. It is one of the highest in the industrial sector and the potential is still huge.
The main business revenue of pharmaceutical preparation and Chinese medicine is 48.45%, accounting for nearly half of the main business revenue of the pharmaceutical industry.The main business growth of traditional Chinese medicine is bright eye, the fastest growth rate is 21.33%.
In terms of profit, the profit ratio of chemical pharmaceutical preparation and the manufacture of Chinese medicine is 54.15%, which is the fastest growing in the production of biological products and the processing profit of traditional Chinese medicine.
Traditional Chinese medicine is red, actually have trace to follow.
According to the Wind statistics, 17 of the 18 TCM listed companies that announced the 2017 interim results forecast net profit growth of 20%-484.33 per cent.Among them, the Chinese medicine yinpian plate has been the highlight of the growth of traditional Chinese medicine enterprises, and the traditional Chinese medicine yinpian has become the main business area to promote the development of TCM enterprises.
Xu jixi, an analyst with industrial securities, said earlier that the sector has a strong growth momentum and a huge potential for segmentation.
In 2009, Chinese medicine yinpian were included in the national list of essential medicines, to promote the development of Chinese medicine yinpian industry and industrial output rose to 9.643 billion yuan in 2004 from 131.976 billion yuan in 2013, average annual compound growth rate of 33.74%, Chinese medicine yinpian industry growth rate significantly higher than the pharmaceutical industry overall growth.
▍ attached: in the first half of 2017 completion pharmaceutical industry leading economic indicators
I. industrial added value
Value added of the pharmaceutical industry over the scale of the first half of 2017 year-on-year growth of 11.3%, grew by 1% year on year, the overall growth rate of 4.4%, higher than the national industry in the whole industry, pharmaceutical industry added value in the whole industrial added value accounted for 3.3%.
Ii. Main business income
In the first half of 2017, the company's main business revenue reached 1534.4 billion yuan, up 12.39 percent year on year, and 2.25 percentage points higher than the year-ago period.Among the sub-sectors, the fastest growth was in the processing of traditional Chinese medicine, which was slower than the industry average for the growth of pharmaceutical preparations, Chinese medicine and pharmaceutical equipment.
In the first half of 2017, the main business revenue of pharmaceutical industry
(form production: cypress blue)
Three, profits,
In the first half of 2017, the total profit of enterprises in the pharmaceutical industry was 168.652 billion yuan, a year-on-year increase of 15.83%, and 1.22 percentage points higher than that of the previous year.Among the sub-sectors, the fastest growth was in the manufacture of biological products and the processing of traditional Chinese medicine, with negative growth in pharmaceutical equipment.In the first half of 2017, the main revenue margin of the pharmaceutical industry was 11.01%, which was 3.88 percentage points higher than the overall national level.
Total medical industry profit in the first half of 2017
(form production: cypress blue)
Iv. Export volume
In the first half of 2017, the number of enterprises in the pharmaceutical industry in the first half of the year reached 99411 million yuan, up 5.49% from the same period last year.According to customs import and export data, the export volume of pharmaceutical products in the first half of 2017 was us $28.824 billion, up 5.47% year on year.
Investment in fixed assets
In the first half of 2017, pharmaceutical manufacturing completed fixed asset investment of 284.6 billion yuan, up 2.7 percent year on year, compared with 2.8 percentage points in the overall growth rate of manufacturing.
|
| |
Previous article：The director of the hospital of the three - a hospital rises the cost, one thousand yuan!
Next article：Consistency evaluation progress data + four provinces waived the list depth profile
|
| |
|
|
